[Serious lung disease in RA and TNF-blockade--is there a connection?].
Turesson
Carl
C
Jacobsson
Lennart
L
Saxne
Tore
T
Geborek
Pierre
P
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D011658:Pulmonary Fibrosis / Q000139:chemically induced*; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab